Searched for
NOVO NORDISK
Novo partners with Anthropic to speed up drug development with ClaudeThe Danish drugmaker will initially test Anthropic models and Claude Science in its research and development workflows, and address scienti...- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- From Maggi to Thums Up, India's food debate turns to what global brands sell hereIndia's proposal for food health warning labels ignites a national discussion. Companies sell less nutritious versions of brands in India c...
- From hunger to obesity: Developing world faces growing threat to child healthChildhood obesity is rapidly increasing in developing nations, creating a significant health challenge. This epidemic is now outpacing unde...
- Oncology firm Novocure says cyberattack exposed US patient recordsThe breach adds to a growing number of cyberattacks on the healthcare sector, including medical device makers Abbott, Stryker Medtronic a...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
- Eli Lilly launches oral weight-loss pill Foundayo in UKEli Lilly has launched its oral weight management pill Foundayo in the United Kingdom. This new treatment, chemically known as orforglipron...
- Nestle looks to develop new products to serve users of weight-loss drugsNestle is developing specialized products for GLP-1 weight-loss drug users. Artificial intelligence aids in analyzing research and identify...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
- UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
- Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
- Global Market | Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs dataOn Friday, Europe's STOXX 600 index marked its fourth consecutive record closing, driven primarily by technology stocks that mirrored the s...
- School Assembly News Headlines, August 6, 2026: Top national, international, business, sports updates and thought of the daySchool Assembly News Headlines: The Lok Sabha in India has successfully passed a significant bill aimed at modernizing banking evidence law...
- Global Market: European shares climb as earnings, US-Iran diplomacy lift sentimentEuropean stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...
- Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
- Drugmaker Amgen discloses data breach involving patient health informationOn July 29, Amgen determined the incident was material, based on its evaluation of how many files appeared to be affected and the possibi...
- Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug adsNovo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...
- Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drugNovo Nordisk has sued Eli Lilly in a U.S. court. The Danish company accuses Lilly of false advertising for its weight-loss medicines. Novo ...
Load More
